Arwed Cleve

702 total citations
21 papers, 547 citations indexed

About

Arwed Cleve is a scholar working on Genetics, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Arwed Cleve has authored 21 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in Arwed Cleve's work include Estrogen and related hormone effects (13 papers), Steroid Chemistry and Biochemistry (8 papers) and Synthesis and Reactions of Organic Compounds (3 papers). Arwed Cleve is often cited by papers focused on Estrogen and related hormone effects (13 papers), Steroid Chemistry and Biochemistry (8 papers) and Synthesis and Reactions of Organic Compounds (3 papers). Arwed Cleve collaborates with scholars based in Germany and France. Arwed Cleve's co-authors include Wolfgang Schwede, Bernard Haendler, Hartmut Rehwinkel, Roland Neuhaus, Marcus Bauser, Thomas Müller, Bernd Buchmann, Hölger Siebeneicher, Iring Heisler and Günter Neef and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Arwed Cleve

21 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arwed Cleve Germany	10	269	128	103	91	76	21	547
Wolfgang Schwede Germany	13	204 0.8×	77 0.6×	106 1.0×	158 1.7×	162 2.1×	34	584
Leslie Hodges-Gallagher United States	15	360 1.3×	84 0.7×	306 3.0×	44 0.5×	189 2.5×	24	804
Denis McCann United States	15	566 2.1×	63 0.5×	71 0.7×	85 0.9×	149 2.0×	26	826
Koc-Kan Ho United States	12	328 1.2×	82 0.6×	44 0.4×	64 0.7×	73 1.0×	17	476
Ana Krivokuća Serbia	15	188 0.7×	95 0.7×	52 0.5×	92 1.0×	179 2.4×	46	559
Surojeet Sengupta United States	18	437 1.6×	142 1.1×	289 2.8×	45 0.5×	283 3.7×	33	864
Philipp Y. Maximov United States	17	293 1.1×	94 0.7×	421 4.1×	101 1.1×	204 2.7×	26	760
Reiko Hirose Japan	15	297 1.1×	58 0.5×	162 1.6×	32 0.4×	64 0.8×	25	521
Jennifer M. Grad United States	7	432 1.6×	86 0.7×	118 1.1×	15 0.2×	126 1.7×	7	661
Tze Howe Charn United States	6	374 1.4×	94 0.7×	299 2.9×	43 0.5×	143 1.9×	7	586

Countries citing papers authored by Arwed Cleve

Since Specialization

Citations

This map shows the geographic impact of Arwed Cleve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arwed Cleve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arwed Cleve more than expected).

Fields of papers citing papers by Arwed Cleve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arwed Cleve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arwed Cleve. The network helps show where Arwed Cleve may publish in the future.

Co-authorship network of co-authors of Arwed Cleve

This figure shows the co-authorship network connecting the top 25 collaborators of Arwed Cleve. A scholar is included among the top collaborators of Arwed Cleve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arwed Cleve. Arwed Cleve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siemeister, Gerhard, Anne Mengel, Amaury E. Fernández‐Montalván, et al.. (2018). Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors In Vitro and In Vivo. Clinical Cancer Research. 25(4). 1404–1414. 53 indexed citations

Möller, Carsten, Wilhelm Bone, Arwed Cleve, et al.. (2018). Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies. ChemMedChem. 13(21). 2271–2280. 26 indexed citations

Siemeister, Gerhard, Anne Mengel, Wilhelm Bone, et al.. (2017). Abstract 287: BAY 1816032, a novel BUB1 kinase inhibitor with potent antitumor activity. Cancer Research. 77(13_Supplement). 287–287. 3 indexed citations

Siebeneicher, Hölger, Arwed Cleve, Hartmut Rehwinkel, et al.. (2016). Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876. ChemMedChem. 11(20). 2261–2271. 212 indexed citations

Sugawara, Tatsuo, Pascale Lejeune, Roland Neuhaus, et al.. (2016). BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients. Oncotarget. 7(5). 6015–6028. 8 indexed citations

Cleve, Arwed, K.-H. Fritzemeier, Bernard Haendler, et al.. (2012). Pharmacology and Clinical Use of Sex Steroid Hormone Receptor Modulators. Handbook of experimental pharmacology. 543–587. 26 indexed citations

Haendler, Bernard & Arwed Cleve. (2011). Recent developments in antiandrogens and selective androgen receptor modulators. Molecular and Cellular Endocrinology. 352(1-2). 79–91. 51 indexed citations

Cleve, Arwed, Ulrich Klar, & Wolfgang Schwede. (2004). Beneficial effects of fluorine in the anti-progestin ZK 230211. Journal of Fluorine Chemistry. 126(2). 217–220. 14 indexed citations

Hoffmann, Jens, Rosemarie B. Lichtner, U. Fuhrmann, et al.. (2004). P48 Progesterone receptor antagonists an alternative for breast cancer prevention. European Journal of Cancer Supplements. 2(1). 56–56. 1 indexed citations

10.

Cleve, Arwed, et al.. (2000). An Efficient Synthesis of 11β-(4-Aminophenyl)spiro[estr-4-ene-17β,2′(5′H)-furan]-3,5′-dione. Tetrahedron. 56(35). 6489–6492. 3 indexed citations

11.

Fuhrmann, Ulrike, Holger Hess‐Stumpp, Arwed Cleve, et al.. (2000). Synthesis and Biological Activity of a Novel, Highly Potent Progesterone Receptor Antagonist. Journal of Medicinal Chemistry. 43(26). 5010–5016. 80 indexed citations

12.

Neef, Günter, et al.. (1997). Synthesis and spectroscopic peculiarities of 11β-aryl-estra-4,8(14),9-trienes and 11β-aryl-estra-5(10),6,8-trienes. Tetrahedron Letters. 38(22). 3897–3900. 2 indexed citations

13.

Ottow, Eckhard, Arwed Cleve, Günter Neef, & Wolfgang Schwede. (1997). Highly diastereoselective synthesis of 11β,17β-diaryl-18a-homo-19-nor steroids. Journal für praktische Chemie. 339(1). 365–370. 2 indexed citations

14.

Cleve, Arwed, K.-H. Fritzemeier, Nikolaus Heinrich, et al.. (1996). ChemInform Abstract: 11β‐Aryl Steroids in the Androstene Series. The Role of the 11. beta.‐Region in Steroid Progesterone Receptor Interaction.. ChemInform. 27(20). 1 indexed citations

15.

Cleve, Arwed, Günter Neef, Eckhard Ottow, Stefan Scholz, & Wolfgang Schwede. (1995). Synthesis of 14β-H antiprogestins. Tetrahedron. 51(19). 5563–5572. 20 indexed citations

16.

Cleve, Arwed, et al.. (1995). ChemInform Abstract: Synthesis of 14β‐H Antiprogestins.. ChemInform. 26(39). 1 indexed citations

17.

Schwede, Wolfgang, et al.. (1994). Synthesis and biological activity of 17-chloro-16(17) unsaturated D-homo antiprogestins. Steroids. 59(3). 176–180. 6 indexed citations

18.

Schwede, Wolfgang, Arwed Cleve, Eckhard Ottow, & Rudolf Wiechert. (1993). Synthesis of 11α-methyl-11β-(arylethynyl) substituted steroids of the estrane series. Tetrahedron Letters. 34(33). 5257–5260. 9 indexed citations

19.

Cleve, Arwed, Eckhard Ottow, Günter Neef, & Rudolf Wiechert. (1993). Synthesis of oxygen-bridged antigestagens. Tetrahedron. 49(11). 2217–2226. 4 indexed citations

20.

Cleve, Arwed & Ferdinand Bohlmann. (1989). Synthesis of (±)-senoxepin - the first naturally occurring anti-hückel oxepin derivative. Tetrahedron Letters. 30(10). 1241–1244. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact